Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer

PURPOSE: In ovarian cancer, there are two main routes of metastasis, namely intraperitoneal and retroperitoneal. Their biologic background is poorly understood. Identifying molecular markers involved might enable the development of tailored therapy regimens. Moreover, no reliable markers for respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Volk, Annabelle, Legler, Karen, Hamester, Fabienne, Kuerti, Sascha, Eylmann, Kathrin, Rossberg, Maila, Schmalfeldt, Barbara, Oliveira-Ferrer, Leticia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620258/
https://www.ncbi.nlm.nih.gov/pubmed/37684509
http://dx.doi.org/10.1007/s00432-023-05354-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620258/
https://www.ncbi.nlm.nih.gov/pubmed/37684509
http://dx.doi.org/10.1007/s00432-023-05354-1

Ejemplares similares